Brief: Theratechnologies Reports Q2 Loss Per Share Of $0.08
July 15 (Reuters) - Theratechnologies Inc TH.TO :
* THERATECHNOLOGIES ANNOUNCES FINANCIAL RESULTS FOR THE
SECOND
QUARTER OF FISCAL 2020
* QTRLY TOTAL PRODUCT REVENUES OF $17.2 MILLION, A 10%
INCREASE
* SUPPLY CHAIN AND PRODUCT INVENTORY REMAIN UNAFFECTED BY
COVID-19
PANDEMIC
* Q2 LOSS PER SHARE $0.08
* Q2 EARNINGS PER SHARE VIEW $-0.05, REVENUE VIEW $17.0
MILLION --
REFINITIV IBES DATA
Source text for Eikon: ID:nGNX1VrwPv
Further company coverage: TH.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Theratechnologies
See all newsBrief: Theratechnologies Receives Final Court Approval On To Be Acquired By Future Pak
Brief: Theratechnologies Inc - Iss And Glass Lewis Recommend Voting 'For' Future Pak Arrangement
Canadian drugmaker Theratechnologies beats Q2 revenue estimates on strong demand
Brief: Theratechnologies Enters Into Definitive Agreement To Be Acquired By Cb Biotechnology, An Affiliate Of Future Pak
Brief: Theratechnologies Inc Decided To Further Evaluate Potential Sale Of Company Through An Open And Non-Exclusive Process